Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Inflammation wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Acute pancreatitis wikipedia , lookup
Management of multiple sclerosis wikipedia , lookup
Autoimmune encephalitis wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Pathophysiology of multiple sclerosis wikipedia , lookup
Multiple sclerosis signs and symptoms wikipedia , lookup
Sent to Peter Tsai-November 2003 Mtg ABSTRACT Presenter: Dr. David J. Kelvin Title: Immune Responses in Paitents with Severe Acute Respiratory Syndrome (SARS): Lessons from Cytokine and Gene expression Profiling, FACS Analysis, and Epitope Mapping” A novel coronavirus has been identified as the etiologic agent for severe acute respiratory syndrome (SARS). Individuals infected with SARS present with fever, cough and myalgia that may progress to lung inflammation including acute respiratory distress syndrome. We analyzed tissue and blood samples collected longitudinally from suspect or probable SARS patients during the prodrome, acute phase of SARS and convalescence for the expression of CXCL10. As controls we collected samples from healthy individuals, suspect SARS cases and individuals that presented with SARS-like symptoms. CXCL10 is an inflammatory chemokine that is induced by interferon cytokines. It’s cognate receptor, CXCR3, is expressed on lymphocyte poplulations and most highly expressed on memory and activated T cells. CXCL10 has been shown to be critical in the defense against neurotropic coronavirus infection in animal models. There was an overall increase in CXCL10 plasma levels in probable SARS patients compared to non-SARS individuals as well as convalescent individuals. During the course of the disease, plasma levels of CXCL10 decreased in patients that went on to recovery but remained elevated in patients that died. Using real-time PCR, we also investigated the expression of CXCL10 and CXCR3 in peripheral blood and lung autopsy tissue from SARS patients. There was an increased expression of both CXCL10 and CXCR3 in both peripheral blood and the lung tissues in comparison to controls. We hypothesize that the maintenance of high CXCL10 expression in the lung in SARS patients may generate a positive feedback loop resulting in the continual recruitment of activated T cells leading to severe lung inflammation. CXCL10 may be a useful target for both diagnostic and therapeutic modalities.